The trademark application Endoclot was filed by BioCer Entwicklungs-GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on August 9, 2021, and it was registered by office on November 16, 2021 without any oppositions.
The application was filed in German (English was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2021.The first Cancellation was filed by EndoClot Plus, Inc. (represented by PAUL & ALBRECHT PATENTANWÄLTE PARTG MBB) on February 27, 2023 and Final decision – EUTM partially cancelled.
Application for revocation or for a declaration of invalidity of the trademark registration was recorded on April 11, 2022. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on March 15, 2023. Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on May 21, 2023.
The Cancellation with reference B 000053923 was EUTM partially cancelled according to Article 60(1)(a) EUTMR with decision issued on November 28, 2022 by the EUIPO.